Sawai Group HoldingsSAWAI GROUP HOLDINGS Co., Ltd.4887東証プライム医薬品FY ending Mar 2026, consolidated, IFRS
Out of every ¥100 of sales, about ¥8 is left as operating profit. Revenue changed +14.0% from the prior year, operating profit -14.6%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: ending assets and ending equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | — | —× | -8.1% | —× | — |
| 2023 | 7.7% | 0.46× | 3.5% | 1.77× | 6.3% |
| 2024 | 7.7% | 0.47× | 3.7% | 1.80× | 6.6% |
| 2026 | 5.2% | 0.56× | 2.9% | 2.02× | 5.8% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2026 |
|---|---|---|---|---|
| Revenue | 193,816 | 163,702 | 176,862 | 201,676 |
| Cost of revenue | — | 113,450 | 122,543 | 142,882 |
| Gross profit | — | 50,252 | 54,319 | 58,793 |
| SG&A | — | 22,245 | 23,244 | 26,056 |
| Operating income | — | 16,054 | 18,620 | 15,894 |
| Pretax income | -36,214 | 15,850 | 18,262 | 14,273 |
| Income tax | — | 3,954 | 5,583 | 2,737 |
| Net income attributable to owners | -28,269 | 12,667 | 13,695 | 10,438 |
| Operating margin | — | 9.8% | 10.5% | 7.9% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2026 |
|---|---|---|---|---|
| Cash and equivalents | ¥47.7B | ¥33.1B | ¥26.4B | ¥29B |
| Total assets | ¥349.5B | ¥364.2B | ¥382B | ¥359.9B |
| Net assets | — | ¥212.7B | ¥218B | ¥178.6B |
| Share capital | — | ¥10B | ¥10B | ¥10.1B |
| Property, plant and equipment | — | ¥121.3B | ¥103.4B | ¥115.6B |
| Goodwill | — | — | — | ¥13M |
| Current assets | — | ¥205.3B | ¥240B | ¥200.3B |
| Total liabilities | — | ¥151.4B | ¥164B | ¥181.4B |
| Equity attributable to owners of parent | — | ¥201.6B | ¥212.7B | ¥178.6B |
| Retained earnings | — | ¥141.6B | ¥149.6B | ¥161.6B |
| Treasury stock | — | -¥2M | -¥2M | -¥3M |
EDINET (FSA Japan)
有価証券報告書－第5期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第4期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第3期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第2期(2022/04/01－2023/03/31)
Extracted from XBRL: 44 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.